The release of Semaglutide at a 45mg level represents a notable development in addressing diabetes. Before, smaller doses were usually used, but this latest formulation offers the potential for improved glucose control in some people. Healthcare professionals are assessing its effectiveness and safety profile, specifically in individuals who hav… Read More